Apixaban safer than rivaroxaban in AF with liver disease, doctors say
Doctors can be reassured that apixaban is safe for patients with AF and liver disease, a retrospective cohort study suggests. The Harvard University-led study found…
Tag: Anticoagulant
Safe to stop anticoagulants three months after VTE linked to COVID-19, study suggests
Long-term anticoagulation may be unnecessary in patients with COVID-19-associated VTE, with doctors reporting low rates of recurrence after stopping therapy. Their study of 1100 adults…
Coroners don’t always get it right when they scrutinise patient deaths
Having spent most of my working life in hospital emergency medicine, including roles in ED management, policy development and standards-setting, I am generally alert for…
Concomitant SSRIs and oral anticoagulants up major bleed risk: study
Concomitant use of SSRIs and oral anticoagulants increases the risk of major bleeding by a third in older adults with AF compared with use of…
Prolonged NOACs beat warfarin for lowering recurrent VTE risk: study
Patients prescribed extended anticoagulation for VTE have a lower risk of recurrent VTE with NOACs compared to warfarin, according to a study in JAMA Network…
Watch for ‘rare but serious’ side effect from oral anticoagulants: TGA
The medicines watchdog has slapped safety warnings on all oral anticoagulants following post-marketing reports of anticoagulant-related nephropathy presenting as acute kidney injury. On Thursday, the…
When investigations don’t match clinical findings
Earl is an 88-year-old retired teacher who presents to his GP with gross swelling of the left upper limb for the past 24 hours. The…
Anticoagulant proves ‘promising’ in reducing dementia risk
Australian study shows AF patients on NOACs are less likely to experience cognitive decline than those on warfarin.
Which patients need anticoagulation after COVID-19 hospitalisation?
US researchers find three risk factors are linked to an increased risk of VTE after discharge.
Pre-hospital heparin ‘may improve coronary reperfusion’
Aus researchers say their study has set the scene for a randomised controlled trial that could change practice
